Erik Buchholz
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Erik Buchholz's research examines factors influencing cognitive health and aging, with a focus on longitudinal associations and predictive biomarkers. His work investigates the long-term impact of early-life behaviors, such as cigarette smoking, on predicted brain aging. Buchholz also studies the relationship between biological markers, like plasma neurofilament light chain, and cognitive function in older adults. His research explores the role of frailty in predicting Alzheimer's disease-related biomarkers and brain structure changes. Additionally, Buchholz has investigated the genetic and environmental influences on alcohol consumption across the lifespan and the relationships between midlife physical activity and later-life cognitive functioning. He has collaborated with researchers including Nitin Agarwal and Esther Mead, and has published 15 papers with 31 citations, holding an h-index of 3.
Metrics
- h-index: 3
- Publications: 15
- Citations: 31
Selected Publications
-
Practice effects persist over two decades of cognitive testing: Implications for longitudinal research (2025)
-
Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age (2025)
-
Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age (2025)
-
Does attachment get under our skin? Midlife attachment style predicts mild cognitive impairment and cumulative deficit frailty in old age (2024)
-
Midlife cumulative deficit frailty predicts Alzheimer’s disease-related plasma biomarkers in older adults (2024)
-
Applying an Epidemiological Model to Evaluate the Propagation of Misinformation and Legitimate COVID-19-Related Information on Twitter (2021)
-
Using Diffusion of Innovations Theory to Study Connective Action Campaigns (2021)
Collaboration Network
Top Collaborators
- Midlife cumulative deficit frailty predicts Alzheimer’s disease-related plasma biomarkers in older adults
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Does attachment get under our skin? Midlife attachment style predicts mild cognitive impairment and cumulative deficit frailty in old age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Practice effects persist over two decades of cognitive testing: Implications for longitudinal research
- Midlife cumulative deficit frailty predicts Alzheimer’s disease-related plasma biomarkers in older adults
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Practice effects persist over two decades of cognitive testing: Implications for longitudinal research
- Midlife cumulative deficit frailty predicts Alzheimer’s disease-related plasma biomarkers in older adults
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Midlife cumulative deficit frailty predicts Alzheimer’s disease-related plasma biomarkers in older adults
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Practice effects persist over two decades of cognitive testing: Implications for longitudinal research
- Midlife cumulative deficit frailty predicts Alzheimer’s disease-related plasma biomarkers in older adults
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Practice effects persist over two decades of cognitive testing: Implications for longitudinal research
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Practice effects persist over two decades of cognitive testing: Implications for longitudinal research
- Applying an Epidemiological Model to Evaluate the Propagation of Misinformation and Legitimate COVID-19-Related Information on Twitter
- Using Diffusion of Innovations Theory to Study Connective Action Campaigns
- Applying an Epidemiological Model to Evaluate the Propagation of Misinformation and Legitimate COVID-19-Related Information on Twitter
- Using Diffusion of Innovations Theory to Study Connective Action Campaigns
- Midlife cumulative deficit frailty predicts Alzheimer’s disease-related plasma biomarkers in older adults
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Practice effects persist over two decades of cognitive testing: Implications for longitudinal research
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Associations of Lancet Commission risk factors for Alzheimer's disease with blood‐based biomarkers and mild cognitive impairment from midlife to early old age
- Association of cumulative deficit frailty with brain age and Alzheimer’s disease-related brain structure starting in late-middle age
- Practice effects persist over two decades of cognitive testing: Implications for longitudinal research
Similar Researchers
Based on overlapping research topics